NVision is a developer of MRI polarizers and hyperpolarized imaging agents. The company’s hyperpolarization technology permits the assessment of human and animal metabolism by standard MRI, enabling advanced preclinical and clinical applications, including novel cancer diagnosis and monitoring of response to therapy. 2023 delivery of first polarizers to users.
Location: Germany, Baden-Württemberg, Ulm
Employees: 51-200
Total raised: $31.7M
Founded date: 2015
Investors 4
| Date | Name | Website |
| - | Matterwave... | matterwave... |
| - | b2venture | b2venture.... |
| - | Playground... | playground... |
| - | Playground... | playground... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 23.06.2023 | Series A | $30M | - |
| 01.01.2022 | Grant | $1.7M | - |
Mentions in press and media 3
| Date | Title | Description | Source |
| 23.06.2023 | NVision Imaging Raises $30M in Series A Funding | NVision Imaging, a Ulm, Germany-based developer of MRI polarizers and hyperpolarized imaging agents,... | finsmes.co... |
| 14.02.2023 | Quantum Brilliance snags $18M funding on synthetic diamond r... | Quantum Brilliance hit the quantum computing scene in 2019 with an ambitious vision to apply synthet... | venturebea... |
| - | NVision Imaging Technologies | “NVision Imaging Technologies is leveraging advances in quantum physics to enable the first routine,... | fastfounde... |